Lawson Kroeker Investment Management Inc Gilead Sciences, Inc. Transaction History

Lawson Kroeker Investment Management Inc

$500 Million
Q4 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	SELL	$77.31 - $88.08 $3.61 Million - $4.11 Million	-46,666 Reduced 81.31%	10,730 $890,000
Q4 2022 Jan 17, 2023	SELL	$62.32 - $89.47 $218,431 - $313,592	-3,505 Reduced 5.76%	57,396 $0
Q3 2022 Oct 11, 2022	BUY	$59.54 - $68.01 $893 - $1,020	15 Added 0.02%	60,901 $3.76 Million
Q2 2022 Jul 11, 2022	SELL	$57.72 - $65.01 $80,808 - $91,014	-1,400 Reduced 2.25%	60,886 $3.76 Million
Q1 2022 Apr 11, 2022	BUY	$57.92 - $72.58 $71,415 - $89,491	1,233 Added 2.02%	62,286 $3.7 Million
Q4 2021 Jan 10, 2022	SELL	$64.88 - $73.64 $9,407 - $10,677	-145 Reduced 0.24%	61,053 $4.43 Million
Q3 2021 Oct 12, 2021	SELL	$67.69 - $73.03 $71,074 - $76,681	-1,050 Reduced 1.69%	61,198 $4.28 Million
Q2 2021 Jul 12, 2021	BUY	$63.47 - $69.35 $31,290 - $34,189	493 Added 0.8%	62,248 $4.29 Million
Q1 2021 Apr 09, 2021	BUY	$60.0 - $68.46 $124,620 - $142,191	2,077 Added 3.48%	61,755 $3.99 Million
Q4 2020 Jan 13, 2021	SELL	$56.65 - $64.55 $1.46 Million - $1.66 Million	-25,755 Reduced 30.15%	59,678 $3.48 Million
Q3 2020 Oct 13, 2020	SELL	$62.1 - $78.08 $3,105 - $3,904	-50 Reduced 0.06%	85,433 $5.4 Million
Q2 2020 Jul 13, 2020	SELL	$72.34 - $84.0 $17,361 - $20,160	-240 Reduced 0.28%	85,483 $6.58 Million
Q1 2020 Apr 21, 2020	BUY	$62.63 - $80.22 $1.46 Million - $1.87 Million	23,340 Added 37.41%	85,723 $6.41 Million
Q4 2019 Jan 16, 2020	SELL	$61.62 - $67.78 $151,893 - $167,077	-2,465 Reduced 3.8%	62,383 $4.05 Million
Q3 2019 Oct 08, 2019	SELL	$62.51 - $69.0 $1.19 Million - $1.31 Million	-19,040 Reduced 22.7%	64,848 $4.11 Million
Q2 2019 Jul 16, 2019	SELL	$61.87 - $69.38 $16,395 - $18,385	-265 Reduced 0.31%	83,888 $5.67 Million
Q1 2019 Apr 22, 2019	SELL	$62.53 - $70.05 $54,401 - $60,943	-870 Reduced 1.02%	84,153 $5.47 Million
Q4 2018 Jan 15, 2019	SELL	$60.54 - $79.0 $790,955 - $1.03 Million	-13,065 Reduced 13.32%	85,023 $5.32 Million
Q3 2018 Oct 12, 2018	BUY	$71.28 - $78.92 $65,934 - $73,001	925 Added 0.95%	98,088 $7.57 Million
Q2 2018 Jul 16, 2018	SELL	$64.88 - $75.68 $972,161 - $1.13 Million	-14,984 Reduced 13.36%	97,163 $6.88 Million
Q1 2018 Apr 17, 2018	BUY	$72.84 - $88.8 $3,642 - $4,440	50 Added 0.04%	112,147 $8.46 Million
Q4 2017 Jan 17, 2018	SELL	$71.15 - $83.52 $590,189 - $692,798	-8,295 Reduced 6.89%	112,097 $8.03 Million
Q3 2017 Oct 10, 2017	BUY	$72.11 - $85.47 $8.68 Million - $10.3 Million	120,392	120,392 $9.75 Million

Others Institutions Holding GILD

# of Institutions

1,942

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.12 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.75 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.6 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lawson Kroeker Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lawson Kroeker Investment Management Inc with notifications on news.

Account